Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-19

Clinical Trial Update: A Study of Duloxetine in Fibromyalgia [Phase 3]

View source ↗

Summary

Phase 3 trial of duloxetine for fibromyalgia has completed. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2014-12-19